FSENX | RYVAX | FSENX / RYVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 44 years | 27 years | - |
Gain YTD | 8.628 | 9.615 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.92B | 11.5M | 16,730% |
Annual Yield % from dividends | 1.72 | 0.00 | - |
Returns for 1 year | 18.69 | 8.73 | 214% |
Returns for 3 years | 58.97 | 30.58 | 193% |
Returns for 5 years | 98.64 | 15.86 | 622% |
Returns for 10 years | 62.31 | -57.00 | -109% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSTCX | 40.70 | 0.21 | +0.52% |
Vanguard Strategic Small-Cap Equity Inv | |||
KCIIX | 12.50 | 0.06 | +0.48% |
Knights of Columbus International Eq I | |||
MSIQX | 10.18 | 0.04 | +0.39% |
Morgan Stanley Inst International Eq I | |||
HEMAX | 9.14 | 0.02 | +0.22% |
Janus Henderson Emerging Markets A | |||
SVAAX | 5.96 | N/A | N/A |
Federated Hermes Strategic Value Div A |